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Abstract
Background: The endoplasmic reticulum (ER) is the cellular site for protein folding. ER stress occurs when protein folding
capacity is exceeded. This stress induces a cyto-protective signaling cascades termed the unfolded protein response (UPR)
aimed at restoring homeostasis. While acute ER stress is lethal, chronic sub-lethal ER stress causes cells to adapt by
attenuation of UPR activation. Hepatitis C virus (HCV), a major human pathogen, was shown to cause ER stress, however it is
unclear whether HCV induces chronic ER stress, and if so whether adaptation mechanisms are initiated. We wanted to
characterize the kinetics of HCV-induced ER stress during infection and assess adaptation mechanisms and their
significance.
Methods and Findings: The HuH7.5.1 cellular system and HCV-transgenic (HCV-Tg) mice were used to characterize HCV-
induced ER stress/UPR pathway activation and adaptation. HCV induced a wave of acute ER stress peaking 2–5 days post-
infection, which rapidly subsided thereafter. UPR pathways were activated including IRE1 and EIF2a phosphorylation, ATF6
cleavage and XBP-1 splicing. Downstream target genes including GADD34, ERdj4, p58ipk, ATF3 and ATF4 were upregulated.
CHOP, a UPR regulated protein was activated and translocated to the nucleus. Remarkably, UPR activity did not return to
baseline but remained elevated for up to 14 days post infection suggesting that chronic ER stress is induced. At this time,
cells adapted to ER stress and were less responsive to further drug-induced ER stress. Similar results were obtained in HCV-
Tg mice. Suppression of HCV by Interferon-a 2a treatment, restored UPR responsiveness to ER stress tolerant cells.
Conclusions: Our study shows, for the first time, that HCV induces adaptation to chronic ER stress which was reversed upon
viral suppression. These finding represent a novel viral mechanism to manipulate cellular response pathways.
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Introduction
Hepatitis C virus (HCV) is a hepatotropic, positive-strand RNA
member of the Flaviviridae family [1]. Approximately 170 million
people worldwide are infected with HCV. A notable feature of the
virus is its tendency to cause chronic infection. Only a minority of
infected patients is able to eradicate the virus, and up to 80% of
the patients become chronic carriers. The molecular mechanisms
leading to viral persistency and its ability to evade intracellular
host defenses are multi-fold and only partly understood [2].
Currently, there is no effective vaccine against HCV and anti-viral
therapy has limited efficacy [3].
Similar to other positive-strand RNA viruses, HCV replication
involves the formation of a membrane associated replication
complex [4]. The origin of these membranes can be the
mitochondria, intracellular organelles or the endoplasmic reticu-
lum (ER). Various structural and non-structural HCV proteins
were shown to localize inside the ER lumen or integrated to ER
membrane and to undergo ER-specific modifications [5,6].
The ER is the cellular site for folding and modification of
membrane-bound and secreted proteins. The flux of newly
synthesized proteins into the ER is dynamic. Conditions of ER
stress occur when the amount of proteins entering the ER exceeds
its folding capacity. This imbalance induces a cyto-protective
PLoS ONE | www.plosone.org 1 September 2011 | Volume 6 | Issue 9 | e24660signaling cascade collectively termed the unfolded protein
response (UPR) [7,8]. The mammalian UPR operates in several
parallel pathways, whose sensors are IRE1, PERK and ATF6.
When misfolded proteins accumulate in the ER, IRE1 is activated
by trans-autophosphorylation and splices the mRNA of XBP-1,
which converts the unspliced XBP-1 (XBP-1u), a highly unstable
protein into its spliced form (XBP-1s). XBP-1s is a potent
transcription factor responsible for the transcriptional activation
of the majority of UPR target genes [9]. PERK, a second ER stress
sensor, is activated in a similar fashion to IRE1 and is responsible
for the modulation of protein synthesis in response to ER stress.
Activated PERK phosphorylates eIF2a and leads to general
suppression of protein synthesis and activation of the integrated
stress response [10,11]. ATF6, the third sensor, operates both as a
stress sensor and as a transcription factor. In response to ER stress,
ATF6 translocates from the ER to the Golgi apparatus, where its
N-terminus is released from the membrane by regulated
intramembrane proteolysis [12]. Activation of the UPR leads to
a coordinated and highly regulated response which improves the
efficiency of protein folding, processing and export. In order to
reduce protein load in the ER, the UPR attenuates the flow of
proteins into the ER and decreases protein synthesis, while up-
regulating the expression of chaperones. Finally, it removes
misfolded proteins via activation of ER associated degradation
(ERAD).
The UPR is intimately linked to the apoptotic machinery. Both
IRE1 and PERK, when strongly activated, lead to apoptosis
[13,14]. While acute ER stress conditions signal for cell death,
chronic sub-lethal ER stress causes cellular adaptation and
eventually resistance to apoptosis in a mechanism, which was
suggested to involve modulation of mRNA localization and
stability of UPR components [15].
It was previously shown that in cells stably expressing the HCV
replicon, XBP-1 mRNA undergoes splicing, indicative of ER
stress. However the expression of specific target genes downstream
to XBP-1s responsible for enhanced degradation of misfolded ER
proteins was not elevated. These results suggested that HCV
manipulates the IRE1-XBP-1 pathway of the UPR. It was further
shown that ER stress develops in response to expression of specific
HCV proteins such as the core protein E1, E2, NS2 and NS4B
[16–19]. Whether this response triggers apoptosis or pro-survival
signals is unclear.
It is noteworthy that most of these studies were performed not in
the context of viral infection, but rather by using transfections of
sub-genomic or full-length replicons, as well as cell lines
(hepatocytes and non-hepatocyes) over-expressing specific viral
proteins. As readouts, these studies used mostly luciferase reporters
and were limited to single arms of the UPR. Furthermore, most
did not explore downstream targets of UPR activation or stated
that disrupted activation of UPR exists [16–18,20–22]. More
recently, induction of ER stress was also demonstrated in the
context of the HuH7.5.1 model, a cell culture system which
supports a full replication cycle of HCV [23,24]. All three
pathways of the UPR were activated: PERK underwent
phosphorylation, ATF6 was cleaved and XBP-1 mRNA was
spliced. However, it was not conclusively shown whether the target
genes of the various pathways were correspondingly activated. In
contrast, Lerat et al, showed in a transgenic mouse model
expressing the full replicon of HCV that ER stress genes are not
activated [25]. In addition, Joyce et al, showed that infection of
human hepatocytes by HCV in-vivo in the chimeric SCID/Alb-uPA
mice resulted in enhanced Bip/Grp78 expression, but no
significant activation of UPR target genes [26]. These data may
suggest that the UPR was either partially activated or that its
downstream signaling was suppressed or kept at a minimal level
probably to avoid ER stress-mediated apoptosis. All of the studies
were limited to the acute infection soon after virus introduction.
However, chronic infection by HCV, rather than the acute phase
is the major component of HCV pathology in humans.
In this study we explored whether HCV infection causes
chronic long lasting ER stress conditions, and if so, is adaptation to
continuous ER stress, which was demonstrated to occur in
response to pharmacological ER agents develops. Using the
HuH7.5.1 system we demonstrate that HCV induces the UPR in a
wave-like fashion, which peaks on days 3–5 after infection. The
UPR then subsides but remains active at a low level. This chronic
ER stress conferred adaptation and resistance to further drug-
induced ER stress. Suppression of viral replication using
interferon-a 2a treatment restored UPR responsiveness, indicating
that continues presence of the virus is required for adaptation. To
address this phenomenon in vivo, we used mice expressing the
HCV replicon in their liver (HCV-Tg). These mice displayed basal
low level chronic ER stress and adaptation of UPR when
administered tunicamycin, an ER stressor. These findings
represent a novel mechanism by which chronic HCV infection
may disrupt cellular homeostasis.
Materials and Methods
Cell Culture
Huh 7.5.1 cells, a kind gift from Dr. R Chung (Massachusetts
General Hospital, Boston, MA, USA) [23], were grown in
Dulbecco’s modified Eagle’s medium (DMEM) supplemented
with 10% fetal calf serum, 100 units/ml penicillin, 100 mg/ml
streptomycin and 2 mM-glutamine (Biological Industries, Israel).
Cells were grown at 37uC in a 5% CO2 atmosphere within a
humidified incubator.
JFH1 system
Cell supernatant containing infectious JFH1 HCV 2a virus was
harvested from day 7–20 and frozen at 280uC as previously
described [27]. Culture media from Huh 7.5.1 (80% confluent) in
10 cm dish was removed and replaced by 3 ml of thawed JFH1
viral stock. After 3 h medium was replaced by DMEM. Titration
of viral infection was done as previously described [28]. In brief,
Huh7.5.1 cells were seeded in 96-well plates at 1610
4 cells/well.
Supernatant was serially diluted 10-fold in complete growth
medium and used to infect the seeded cells (6 to 8 wells per
dilution). Following 2 or 3 days of incubation the cells were
immunostained for HCV core protein. Wells that expressed at
least one core expressing cell were counted as positive, The
TCID50 was calculated using the TCID50 calculator http://www.
med.yale.edu/micropath/pdf/infectivity%20calculator.xls as pre-
viously described [29]. Multiplicity of infection (MIO) was
calculated using a conversion formula: http://www.bioon.com./
book/biology/e-protocol/cell/miopfu.htm.
Quantification of HCV RNA by RT-PCR was done as
previously described [27]. In brief: Total RNA was used to
quantify HCV. JFH copy number was calculated according to a
standard curve run in each RT-PCR experiment. The standard
curve was calculated using a series of 10-fold dilutions of
previously titrated JFH-1 plasmid. Titration of JFH-1 was done
with Abbott RealTime HCV assay (Abbott, Illinois, USA), with
previously published primers (Table 1). Viral quantization was
done repeatedly throughout the experiments to ensure equal MIO.
In order to avoid nutrient stress, cells were split when reaching
approximately 80% confluence and growth media was regularly
exchanged. Equal numbers of cells were used for each experiment.
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C57BL/6J HCV-Tg mice expressing the entire HCV 1b ORF
under alpha-1 antitrypsin promoter were kindly provided by Prof.
N.LaMonica(IRBM,‘‘P.Angeletti’’,Pomezia,Italy)[30].C57BL/
6J wt mice (Harlan, Jerusalem, Israel) were used as controls. Animal
care and experiments were approved and conducted in accordance
with the Hebrew University-Hadassah Animal Authority guidelines
(Ethical approval number: MD-1012389-5). Male mice, 10–12
weeks old, 24–26 gr were kept in the SPF unit in the animal facility
at the Hebrew University Medical School. Mice were treated i.p
with tunicamycin (Fermentek, Jerusalem, Israel) injection of 1 mg/
kg (volume of 20 ml/1gr mouse) every other day (total 2–3), and
were sacrificed 3 days following the last injection. Control mice
received 5% dextrose injection in the same volume. Mice were
anesthetized with Ketamine 5 mg/kg (Kepro, Holland) + Xylazine
5%, (Kepro), terminally bled from the heart and sacrificed by
cervical dislocation. Liver samples, were immediately harvested into
liquidnitrogen(and werekept in280uC).A portionwasfixedin4%
formaldehyde (Gadot, Israel) for 24 hrs, and then kept in 70%
ethanol or in 30% sucrose.
Reagents and antibodies
The following antibodies were used: NS5a (Virogen, MA, USA
#276-A), XBP-1 (Santa Cruz CA, #7160), total-IRE1 a (Cell
Signaling #3294) phospho-IRE1a (Abcam, Cambridge, UK,
#48187), phospho/total- eiF2a (Cell Signaling #9721, #9722),
BiP (Abcam #21685), ATF6 (Abcam #11909), CHOP (Santa-Cruz,
#sc-575). Monoclonal mouse antibody against HCV core protein
(Affinity BioReagents, CO, USA, #MA1-080), actin (Abcam
#8227). Thapsigargin (Sigma, MO, USA), 1,000x stocks in DMSO.
Western Blot Analysis
Cells were washed with PBS and lysed for 10 min on ice in
Nonidet P-40 lysis buffer (50 mm Tris, 150 mm NaCl, 2 mm
EDTA, 1% Nonidet P-40, 50 mm NaF, 1 mm Na3VO4, 10 mm
Na2P2O4, protease inhibitor cocktail (Roche, IN, USA)). Lysates
were cleared by centrifugation (14,000 rpm for 15 min at 4uC),
protein concentration was determined and samples were boiled in
reduced Laemmli sample buffer. For tissue samples, liver tissue
was homogenized for 5 minutes with fresh homogenizing buffer
(NaHCO3 1 mM, CaCl2 0.5 mM, 1% Protease Inhibitor and 1%
Phosphatase inhibitor). Samples were centrifuged (2000 rpm for
5 min), and the pellet was treated with RIPA lysis buffer (NaCl
150 mM, NP-40 1%, DOC 0.5%, SDS 0.1% and TRIS 50 mM).
Extracts were centrifuged (14,000 rpm for 10 min) protein
concentration was determined and samples were boiled in reduced
Laemmli sample buffer. Following SDS-PAGE of equal protein
content, gels were transferred to a polyvinylidene difluoride
(PVDF) membrane. Detection was performed using horseradish
peroxidase-linked antibody and chemiluminescence (Santa Cruz).
Membranes were probed with anti-actin to confirm equal loading.
RT-PCR and quantitative RT-PCR
Total cellular RNA was isolated by Trizol reagent (Prio-Lab,
Jerusalem, Israel) according to the manufacturer instructions. For
reverse transcription, 0.5 mg of total RNA were transcribed using
cDNA synthesis kit (Applied Biosystem, CA, USA). Aliquots of
1 ml cDNA were subjected to 35 cycles of PCR amplification.
Actin or Ubc were used as internal control. The primer sequences
are shown in table 1 (Each primer pair was designed to span an
intron). Negative controls included the amplification of samples
without prior RT reaction.
Quantitative RT-PCR was performed in the PCR 7900HT
Real-Time PCR System (Applied Biosystems) using SYBR Green
mix (Applied Biosystems). Briefly, 100 ng of reversed transcribed
cDNA were used for each PCR reaction with 250 nM of forward
and reverse primers. The thermal cycling conditions comprised 4
minutes at 95uC, followed by 35 cycles at 94uC for 30 seconds,
58uC for 5 seconds, and 72uC for 45 seconds. The mRNA level in
untreated cells was defined as 1 arbitrary unit.
Immunofluorescence
Cells were seeded in 24 well plates on cover glass. At specific
time points the cells were washed three times with ice-cold PBS
Table 1. Primers used for real-time PCR.
Human:
Actin-F GCG GGA AATCGT GCG TGA CAT
Actin-R GAT GGA GTT GAA GGT AGT TTC
ATF3-F TTG CAG AGC TAA GCA GTC GTG
ATF3-R ATG GTT CTC TGC TGC TGG GAT TCT
XBP1-spliced-F CTG AGT CCG CAG CAG GTG
XBP1-spliced-R TGC CCA ACA GGA TAT CAG ACT
XBP1-total-F AGT AGC AGC TCA GAC TGC CA
XBP1-total-R CCT GGT TCT CAA CTA CAA GGC
p58IPK-F TTT GCG TTC ACA AGC ACT TAA C
p58IPK-R GTT CTG CAT CCC AAA CAC AAA C
ERdj4-F GGT GTG CCA AAA TCG GCA TC
ERdj4-R GCA CTG TGT CCA AGT GTA TCA TA
GADD34-F ATG ATG GCA TGT ATG GTG AGC
GADD34-R AAC CTT GCA GTG TCC TTA TCA G
Mouse:
p58IPK-F TTTACTGCCGCAAGACTACAG
p58IPK-R CTGGGGTTAGATTTGAGCACTT
ATF3-F CAGACCCCTGGAGATGTCAGT
ATF3-R TTCTTGTTTCGACACTTGGCA
ERdj4-F ATAAAAGCCCTGATGCTGAAGC
ERdj4-R GCCATTGGTAAAAGCACTGTGT
AFT4-F CCTTCGACCAGTCGGGTTTG
AFT4-R CTGTCCCGGAAAAGGCAT
UBC-F CAGCCGTATATCTTCCCAGACT
UBC-R CTCAGAGGGATGCCAGTAATCTA
XBP1 (Total)-F AAGAACACGCTTGGGAATGG
XBP1 (Total)-R ACTCCCCTTGGCCTCCAC
XBP1 (Spliced)-F GAGTCCGCAGCAGGTG
XBP1 (Spliced)-R GTGTCAGAGTCCATGGGA
CHOP-F CTGGAAGCCTGGTATGAGGAT
CHOP-R CAGGGTCAAGAGTAGTGAAGGT
XBP splicing
XBP1-F CCA TGG GGA GAT GTT CTG
XBP1-R CCT GGT TGC TGA AGA GGA
JFH1
F-JFH1: (58–77) CTGTCTTCACGCAGAAAGCG
R-JFH1: (273-254) TCGCAACCCAACGCTACTCG
doi:10.1371/journal.pone.0024660.t001
HCV Induces Chronic ER Stress and Adaptation
PLoS ONE | www.plosone.org 3 September 2011 | Volume 6 | Issue 9 | e24660and fixed with 4% formaldehyde 0.2% Triton-X-100 at room
temperature for 20 min. Cells were washed and incubated with
PBS containing 5% donkey serum, 0.3% Triton X-100, and 10%
FCS for 30 min. Cells were then incubated overnight with
antibody to HCV core protein or CHOP, washed three times with
PBS, and incubated with an anti-mouse antibody conjugated to
Cy5 at a or anti-rabbit Alexa Fluor 488 conjugated (invitrogen,
OR, USA).
Interferon treatment and HCV quantification
Interferon a 2a (IFN-a 2a) (Roferon A, Roche, Basel,
Switzerland) was used to suppress viral replication as previously
described [31]. In brief: cells were infected with JFH-1 HCV 2a
virus as described above. Following infection, 1800IU/ml of IFN-
a 2a were added to cell growth medium and changed daily for the
duration of the experiment. Quantification of HCV RNA was
done by RT-PCR. Total RNA was used to quantify HCV. JFH1
copy number was calculated according to a standard curve that
was done for each experiment. The standard curve was calculated
using a series of 10-fold dilutions of previously titrated plasmid
JFH1. Titration of plasmid JFH1 was performed with the Abbott
RealTime HCV assay (Abbott, IL, USA).
Immunohistochemical staining
Liver samples were fixed in 4% neutral-buffered formalin and
embedded in paraffin. 5 mM sections were dewaxed and hydrated
through graded ethanol dilutions, then cooked in citrate buffer
(pH 6, 10 mM) in a pressure cooker at 115uC for 3 minutes.
Endogenous peroxidase activity was blocked with 3% hydrogen
peroxide followed by washing. The sections were then incubated
with the indicated antibodies: CHOP (1:300, Santa Cruz, SC-
575). Secondary Ab exposure was performed using the Mach 3
Rabbit tool kit (Biocare Medical, CA, USA) following manufac-
turers’ instructions. All sections were counterstained with hema-
toxylin, and were visualized using an Olympus light microscope.
Quantification was performed by visualizing the slides on an
Olympus BX61 microscope, photography was performed on
Photometric CoolSnap ES and analysis was done using Ariol SL-
50 Applied Imaging 3.1.270 software.
Statistical analysis
Statistical significance between groups was assessed by one way
ANOVA adjusted for multiple comparisons and tested for normal
distribution. Data are expressed as means 6 standard deviations
(S.D.). Triplicate determinations were performed in all the real-
time experiments, and all experiments were repeated at least three
times. A p-value equal or less than 0.05 was considered to be
statistically significant.
Results
HCV infection induces a wave like activation of the 3
arms of the UPR
To monitor the induction of UPR following infection by HCV
we used the HuH7.5.1 cell system. Cells were infected with JFH1
2a strain and viral replication was assessed by RT-PCR for viral
RNA and immunoblotting for the viral proteins NS5A and core.
We observed high infectious titers and viral persistence up to 25
days post-infection. Following day 9 post-infection, we observed a
steady-state level without further increases in viral replication. To
ensure equal infection conditions in each experiment TCID50,
MIO and HCV copy number were measured repeatedly as
described in the methods (Figure S1a–b and data not shown).
During culture, cells may display different levels of ER stress/UPR
activation. In order to assess base line levels of ER stress we
cultured non-infected cells in parallel to infected cells. We did not
observe significant activation of ER stress in non-infected cells
during days 1–5 of the experiment (Figure S3a).
Next, we monitored the time course of UPR induction. The
three arms of the UPR were activated simultaneously in a wave-
like pattern. Levels of phosphorylated IRE1, cleaved ATF6 and
phosphorylated eIF2a, peaked on days 3–5 by 4.1360.6 fold,
8.361.8 fold and 13.661.14 fold compared to non-infected cells
(Figure 1a, b and c, respectively), in a manner that coincided with
the peak viral replication. Phosphorylated eIF2a leads to induction
of CHOP and its translocation into the nucleus. Indeed, we
observed accumulation of CHOP in the nucleus of HCV infected
cells as compared to non-infected controls (Figure 1d). XBP-1
splicing followed a similar wave pattern, which reached a peak at
day 3 post infection (Figure 2a). To determine if the IRE1-XBP-1
and PERK-eIF2a arms are transcriptionally active we measured
expression of their direct targets by real time PCR. mRNA levels
of p58
ipk and ERDJ4, ATF3 and ATF4 were up-regulated in a
temporal pattern similar to XBP-1 splicing (3.861.54,
15.1460.37, 31.96615.44 and 2.8661.01 fold increase compared
to non-infected cells, respectively). ATF4 was shown to up-regulate
transcription of several UPR targets including that of the growth
arrest and DNA damage (GADD)34 gene. GADD34 was shown to
promote dephosphorylation of eIF2a via protein phosphatase 1
(PP1c) thereby leading to recovery from translational inhibition in
the UPR. We observed a marked increase in GADD34
transcription peaking on day 3 post-infection (8.161.2 fold
increase compared to non-infected cells) (Figure 2b–f).
ER stress/UPR pathways are interrelated to inflammatory
pathways via IRE1/TRAF2. We therefore looked at associated
inflammatory pathways with regard to ER stress. We observed a
marked increase in the phosphorylation of JNK, peaking on days
3–4 in parallel to the peak of viral replication and the activation of
the three arms of the UPR (Figure S3b). These results suggest that
inflammatory pathways are activated in tandem to UPR pathways.
We conclude that the IRE1-XBP-1-ERdj4-p58
ipkand PERK-
eIF2a-ATF4-ATF3-CHOP-GADD34 pathways are activated
following HCV infection. ATF6 was cleaved, a marker of its
activation. Downstream target genes of ATF6 were not investi-
gated in our study.
HCV infection induces prolonged activation of the UPR
Because HCV establishes a chronic infection and since the UPR
is activated in the course of infection, we wanted to assess whether
HCV induces chronic conditions of ER stress. We analyzed cells
14 days after infection, a time point at which the parameters of
HCV infection, such as expression of viral RNA and viral proteins,
exhibit steady state levels. We compared by real-time PCR the
levels of UPR targets at day 14 to their levels at day 1. We
observed that markers of UPR activation did not return to their
baseline levels 14 days after infection. Both targets of PERK
(CHOP and ATF3) and the IRE1 pathways (spliced XBP-1 and
p58
IPK) were significantly elevated at day 14 relative to day 1 or
non infected cells (Figure 3a–d). Similarly, eIF2a phosphorylation
remained elevated throughout the infection above baseline
(Figure 3e). These results show that HCV infection perturbs the
homeostasis of the ER causing a chronic stress, which leads to a
sustained activation of the UPR.
HCV-induced chronic ER stress confers resistance to drug
induced UPR activation
Artificial induction of chronic ER stress with a sublethal
concentration of tunicamycin or thapsigargin causes adaptation to
HCV Induces Chronic ER Stress and Adaptation
PLoS ONE | www.plosone.org 4 September 2011 | Volume 6 | Issue 9 | e24660further induction of ER stress [15]. To test whether HCV infection
induces a similar adaptation, we treated infected HuH7.5.1 cells at
days 5 and 14 with thapsigargin at increasing concentrations and
measured the induction of IRE1 and eIF2a phosphorylation, and
XBP-1 splicing. Thapsigargin treatment at day 14 caused a
markedly attenuated activation of the UPR as demonstrated by
reduced IRE1 and eIF2a phosphorylation, as well as diminished
XBP-1 splicing compared to day 5 (Figure 4a–c). Our data
indicate that HCV-induced chronic ER stress leads to adaptation
and reduced activation of the UPR in response to chemical
perturbation of protein folding.
HCV-Tg mice display chronic ER stress, activate UPR
genes less efficiently than controls and succumb to ER
stress at higher frequency
Despite the expression of viral RNA and proteins (Figure S2),
HCV-Tg mice exhibit very limited hepatic inflammation. To test
whether chronic ER stress develops in the HCV-Tg mice, we
compared by real-time PCR the liver expression of UPR genes of
HCV-Tg to control animals. At baseline, UPR genes were mildly
elevated in HCV-Tg mice livers (ratio of XBP-1 spliced/total and
CHOP 1.9161.4 and 2.4861.4 respectively compared to controls,
Figure 1. HCV infection induces a wave like activation of the 3 arms of the UPR. HuH7.5.1 hepatoma cells were infected with HCV-JFH1.
Following infection, protein was extracted at the indicated time points. The expression of (a) phospho-IRE1, and (b) cleaved and non-cleavedATF6 (c)
phospho-eIF2a were analyzed by western blotting. (d) CHOP translocation to the nucleus was assessed by immunofluorecence in control HuH7.5.1
cells or JFH1 infected cells on day 5, isotype anti-rabbit IgG was used as control. Results are means6S.D. of 3 experiments. Blots and picture are from
a representative experiment (see also Figure S3a).
doi:10.1371/journal.pone.0024660.g001
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conditions of chronic ER stress (Figure 5a).
To test the development of UPR adaptation in vivo, mice were
injected with tunicamycin twice at a day interval. CHOP
translocation to the nucleus was decreased in HCV-Tg mice
compared to controls (from 15.564.6 to 13.266.6, % of stained/
total area p,0.02) as quantified by an automated cellular scanning
quantization system (Figure 5b), and as observed by immunohis-
tochemistry (Figure 5c). consistent with these data, UPR genes
elevation was attenuated following tunicamycin injections in
HCV-Tg mice compared to wild type controls (3.461.1,
3.161.0, 35.3617.1, 56.8621.3 for ERdj4, p58
ipk, CHOP and
ATF3 respectively p,0.05 for all) (Figure 5d) (N=6 mice in each
group). The attenuation of UPR activation suggests that
adaptation to chronic ER stress occurs in-vivo. In accord with
these data, when a regimen of three injections was used, we
observed higher mortality of HCV-Tg as compared to control-
tunicamycin treated mice (HCV-Tg 9/22 (40.9%) vs. wt 3/
12(25%)).
Our results strongly suggest that HCV-induced chronic ER
stress adaptation compromises the ability to activate the
homeostatic cyto-protective response of the UPR in response to
a strong ER stress induction.
HCV suppression by interferon a treatment reverses the
host cell adaptation to chronic ER stress
To determine whether ER stress adaptation requires the
continuous presence of the virus and to rule out the possibility
that viral infection selected for ER stress resistant cells, we
suppressed viral replication by interferon a 2a. When ER stress
was induced by thapsigargin (Figure 6a), interferon treated cells
responded stronger as assessed by enhanced XBP-1 splicing
Figure 2. Downstream target genes of the UPR are up-regulated following HCV infection. HuH7.5.1 hepatoma cells were infected with
HCV-JFH1. Following infection, cells were harvested and RNA was extracted at the indicated time points. (a) splicing of XBP-1 was measured by RT-
PCR. Gene expression levels of (b) GADD34 (c) p58ipk (d) ERDJ4 (e) ATF3 and (f) ATF4 were determined by real-time PCR relative to b-actin. Results are
means6S.D. of 3 experiments. *=p,0.05 (ANOVA, one way) versus non-infected cells.
doi:10.1371/journal.pone.0024660.g002
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increase in gene expression of CHOP, p58
ipk and ERdj4 following
thapsigargin administration in the interferon treated cells
(Figure 6b). Our data show that viral suppression reverses the
adaptation and restores UPR responsiveness to ER stress. This
indicates an active virus-dependent mechanism of adaptation
rather than a passive selection process in the course of culturing
the infected cells.
Discussion
The ability of HCV to evade eradication is mediated in part by
manipulation of innate immunity [32], disruption of NF-kB signaling,
aberration of cytokine and chemokine secretion [33] and attenuation
of interferon response [34]. The role of ER stress in mediating HCV-
induced liver damage was recently put under intense scrutiny.
Any increase in the influx of proteins into the ER putatively may
elicit conditions of ER stress. Thus, viruses which encode
glycoproteins usually provoke ER stress conditions and induce
the UPR in the course of infection. While the UPR may play a
‘‘mere’’ cyto-protective role to restore homeostasis following viral
infection, evidence accumulated in the context of infection by
different viruses strongly suggest that the UPR is utilized by viruses
for their own benefit and that it plays a direct role in their cell
cycle. For example, under strong ER stress conditions, human
cytomegalovirus (HCMV) fails to replicate [35]. It is therefore not
surprising that HCMV evolved strategies to minimize ER stress in
the course of its replication, for instance by promoting the
synthesis of Bip, the master regulator of ER stress [36]. Moreover,
other viruses of the herpes family, such as EBV, have usurped the
UPR to transcriptionally activate viral genes thereby controlling
their lytic cycle [37].
Figure 3. HCV infection induces prolonged activation of the UPR. HCV infected HuH7.5.1 cells were grown in culture for 14 days and
compared to non-infected cells and day 1 post-infection cells. Cells were harvested, RNA extracted and gene expression levels were determined by
real-time PCR and normalized to b-actin expression. Results are means6S.D. of 3 independent experiments. *=p,0.05 (ANOVA, one way) for day 14
versus non-infected and day 1 infected cells.
doi:10.1371/journal.pone.0024660.g003
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and chronic ER stress may play different and even opposite roles.
For example, deletion of XBP-1 in the liver, which confers ER
stress, impairs triglyceride synthesis and VLDL secretion [38].
Similar findings were found when GADD34, which neutralizes the
PERK pathway of the UPR, was over-expressed in the liver [39].
In contrast, infliction of acute ER stress conditions by tunicamycin
injection in various UPR deficient animals induced robust steatosis
[40]. Interestingly, severe steatosis is also seen in HCV carriers
particularly in genotypes II and III. Taken together, the exact
impact of UPR on liver lipid metabolism may be related to the
level of UPR activation and its duration.
Our data clearly show that in the course of productive HCV
infection all 3 arms of the UPR pathways operate in tandem in a
wave-like pattern, which coincides with the replication of JFH1
(Figure 1 and 2). This suggests that ER stress is proportional to the
general load of viral proteins. Once replication declines, the cells
regain homeostasis, and ER stress decreases but is not terminated
(Figures 3 and 5). This feature has not been previously shown.
Our results suggest that HCV, even at low levels of replication,
constitutively activates the UPR. This may be due to cooperative
activities of various HCV-encoded proteins with respect to their
effect on ER physiology. Indeed, the UPR was measured in
response to over-expression of multiple HCV proteins such as the
structural proteins E1 and E2, core as well as non-structural
proteins [16–20,32]. The fact that we observed hyper eIF2a
phosphorylation at the chronic phase may actively serve the virus,
as E1 and E2 HCV envelope proteins induce eIF2a phosphor-
ylation and repress global translation [17], while maintaining their
synthesis in an eIF2a independent fashion [41]. Other viral
Figure 4. HCV-induced chronic ER stress confers resistance to drug induced UPR. HCV infected cells were stimulated by decreasing doses
of thapsigargin at day 5 and at day 14 post infection and the effect of stimulation on (a) XBP-1 splicing or (b) IRE1 and (c) eIF2a phosphorylation was
assessed by RT-PCR and immunoblotting respectively. Quantification of the results was obtained from densitometric scanning of the blots
(means6S.D.) of 3 experiments. *=p,0.05 (ANOVA, one way) for day 5 versus day 14 post infection.
doi:10.1371/journal.pone.0024660.g004
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[42,43]. Thus the PERK pathway of the UPR signaling is carefully
regulated by the virus to allow optimal protein synthesis for its
benefit.
With respect to human pathology, chronic UPR activation may
reflect the in vivo situation in HCV carriers. Direct evidence in
humans for UPR induction are conflicting as a recent report
demonstrates UPR activation in HCV patients long after the
initial event of infection [44], while another study showed
activation of the three UPR sensors but no induction of UPR-
responsive genes [45]. This may be due to the technical difficulty
to analyze a small proportion of infected cells amidst vast excess of
non-infected hepatocytes.
One of the hallmarks of chronic ER stress is the reduced
sensitivity to further induction of the UPR as described for
chemically-induced chronic ER stress [15]. We observed a similar
phenomenon in HCV infected cells (Figure 4). Hence, the
adaptation to chronic stress is not dependent on the mode of
stress infliction and should be taken into account in physiological
and pathological contexts. Moreover, mice that constitutively
express the viral RNA and proteins directed by a liver specific
promoter also display characteristics of adaptation (Figure 5).
Therefore, the chronic adaptation does not require acute
conditions associated with the initial phase of HCV infection.
Interestingly, the HCV-Tg mice succumbed to acute tunicamycin-
induced ER stress at higher frequency than controls. While this
may not be directly related to the handicapped UPR of the
transgenic mice, our data is consistent with the fact that expression
of viral proteins, even without apparent viral replication,
manipulates the UPR in a manner that can be exploited for
Figure 5. HCV-Tg mice display chronic ER stress and activate UPR genes less efficiently than controls following ER stress induction.
Untreated HCV-Tg and control mice were sacrificed, liver excised and RNA was extracted. (a) Expression of the ratio of XBP-1s to XBP-1u (S/T) and
CHOP were assessed by real-time PCR. (Panels b, c and d) Mice were treated i.p. with tunicamycin injection of 1 mg/kg every other day (total of 2–3
injections), and were sacrificed 3 days following the last injection. (c) Immunostaining of formalin-fixed livers for CHOP (b) Quantification of stained
nuclei was done automatically by visualizing the slides on an Olympus BX61 microscope, photography was performed on Photometric CoolSnap ES
and analysis was done using Ariol SL-50 Applied Imaging 3.1.270 software. Untreated mice received 5% dextrose injection.(d) gene expression levels
were determined by real-time PCR relative to UBC expression. Results are means6S.D. of 3 independent experiments. *p,0.05, **p,0.01 (ANOVA,
one way) for (a) untreated control versus HCV-Tg mice and for (b, d) HCV-Tg control versus HCV-Tg tunicamycin treated mice.
doi:10.1371/journal.pone.0024660.g005
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PLoS ONE | www.plosone.org 9 September 2011 | Volume 6 | Issue 9 | e24660Figure 6. Interferon a treatment reverses the adaptation to chronic ER stress. HCV infected cells were treated with Interferon a ´ 2a (1800 IU/
ml were added to cell growth medium and changed daily), or left untreated. On day 14 post infection, cells were stimulated with thapsigargin as
indicated. (a) XBP-1 splicing was assessed by RT-PCR. Quantification of the results was obtained from densitometric scanning of the blots
(means6S.D.) of 3 experiments. *=p,0.05, **p,0.01 for interferon treated versus non-treated cells. (b) Gene expression levels were determined by
real-time PCR and normalized to b-actin expression. Results are means6S.D. of 3 independent experiments. *p,0.05, (ANOVA, one way) for
interferon treated versus non-treated cells.
doi:10.1371/journal.pone.0024660.g006
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shown to regulate ER stress and may potentially act as anti-viral
agents. Of interest, HMG-CoA reductase inhibitors (statins) which
were recently shown to have anti-HCV properties [46], were also
shown to regulate the UPR [47].
Is the adaptation beneficial to the virus? Several studies
demonstrate that chronic ER stress alters biological pathways
relevant to the viral life cycle, such as apoptosis, intracellular lipid
distribution and autophagy. It was shown in HCV expressing cells
from HCV-Tg mice, and liver tissue from HCV infected patients,
that induction of ER stress resulted in up-regulation of protein
phosphatase 2A (PP2A). This led to inhibition of Interferon
signaling and decreased degradation of the anti-apoptotic protein,
Bcl-2 resulting in increased survival of HCV infected cells [48,49].
Thus, we propose that chronic ER stress may serve as a novel
strategy for manipulation of host defenses by the virus for its
benefit. As an additional indication to this hypothesis, viral
suppression by interferon treatment reversed the adaptation
(Figure 6). In conclusion, we show that HCV induces acute and
chronic ER stress and UPR activation resulting in adaptation and
reduced response to further stress. Viral eradication resulted in
regained sensitivity to ER stress and UPR activation. Our study
demonstrates for the first time a biological role of chronic ER
stress in a pathogenic context and highlights the ER stress/UPR
machinery as a possible anti-viral drug target.
Supporting Information
Figure S1 JFH1 HCV fully infective cell system: (a) Titration of
viral infection was done and TCID50 was calculated as described
in the methods. HuH7.5.1 hepatoma cells were infected with the
HCV-JFH1 virus. RNA and protein were extracted on the
indicated times and assessed for (b) HCV RNA (c) NS5A by real-
time PCR and western blotting respectively.
(TIF)
Figure S2 HCV-Tg mice: HCV-Tg and control mice were
sacrificed, liver excised and protein extracted and assessed for
HCV-Core protein by western blotting.
(TIF)
Figure S3 ER stress and JNK phosphorylation are induced in
HCV infected cells: Infected and non-infected HuH7.5.1 cells
were grown in parallel under the same conditions of nutrient
supply and cell density. Following infection, protein was extracted
at the indicated time points. The expression of (a) phospho-IRE1,
total IRE1, phospho- eIF2a and total eIF2a and (b) phospho and
total JNK were analyzed by western blotting. Actin was used as a
loading control.
(TIF)
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